Literature DB >> 15261138

Focus on Barrett's esophagus and esophageal adenocarcinoma.

Thomas G Paulson1, Brian J Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15261138     DOI： 10.1016/j.ccr.2004.06.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  42 in total

1.  Math1/Atoh1 contributes to intestinalization of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20.

Authors:  Jianping Kong; Mary Ann S Crissey; Antonia R Sepulveda; John P Lynch
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 2.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

4.  Barrett's esophagus and animal models.

Authors:  Ryan A Macke; Katie S Nason; Ken-ichi Mukaisho; Takanori Hattori; Takashi Fujimura; Shozo Sasaki; Katsunobu Oyama; Tomoharu Miyashita; Tetsuo Ohta; Koichi Miwa; Michael K Gibson; Ali Zaidi; Usha Malhotra; Ajlan Atasoy; Tyler Foxwell; Blair Jobe
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

Review 5.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

6.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

7.  Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry.

Authors:  Vivek Nandakumar; Laimonas Kelbauskas; Roger Johnson; Deirdre Meldrum
Journal:  Cytometry A       Date:  2011-01       Impact factor: 4.355

8.  Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.

Authors:  Hector Alvarez; Pamela Leal Rojas; Ken-Tye Yong; Hong Ding; Gaixia Xu; Paras N Prasad; Jean Wang; Marcia Canto; James R Eshleman; Elizabeth A Montgomery; Anirban Maitra
Journal:  Nanomedicine       Date:  2008-08-08       Impact factor: 5.307

9.  Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.

Authors:  Shumei Song; Dipen M Maru; Jaffer A Ajani; Chia-Hsin Chan; Soichiro Honjo; Hui-Kuan Lin; Arlene Correa; Wayne L Hofstetter; Marta Davila; John Stroehlein; Lopa Mishra
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

10.  Inhibition of nucleostemin upregulates CDX2 expression in HT29 cells in response to bile acid exposure: implications in the pathogenesis of Barrett's esophagus.

Authors:  Yong-Gang Sun; Xing-Wei Wang; Shi-Ming Yang; Gang Zhou; Wei-Qiang Wang; Hong-Bin Wang; Rong-Quan Wang; Dian-Chun Fang
Journal:  J Gastrointest Surg       Date:  2009-05-16       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.